U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352618) titled '"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial"' on Jan. 12.
Brief Summary: The goal of this clinical trial is to learn if Omega-3 works to control glycemic status, improve lipid profile in Type2 Diabetic patients. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are:
Does drug Omega-3 control glycemic status, improve lipid profile in Type2 Diabetic patients? What medical problems do participants have when taking drug Omega-3? Researchers will compare Omega-3 to a plac...